Interpace Diagnostics (IDXG) Reports Q4 EPS of $3.24

Interpace Diagnostics (NASDAQ: IDXG) reported Q4 EPS of $3.24, versus ($4.59) reported last year. Revenue for the quarter came in at $3.1 thousand, versus $13.09 thousand reported last year.

For earnings history and earnings-related data on Interpace Diagnostics (IDXG) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• MP Materials seen largely insulated after China export-control move